Navigation Links
The Lustgarten Foundation Awards Six Research Centers With Pancreatic Cancer Research Funding
Date:6/23/2009

Foundation Expects to Double 2009 Grant Awards to Nearly $4 Million

BETHPAGE, N.Y., June 23 /PRNewswire-USNewswire/ -- The Lustgarten Foundation, the nation's largest private supporter of pancreatic cancer research, today announced its first round of 2009 grants, totaling $1.6 million awarded to six leading research centers for early diagnostic tests and better treatment for one of the nation's deadliest cancers.

Lustgarten is expected to award nearly $4 million this year, double last year's amount, to scientists engaged in groundbreaking fundamental research. The increase is largely due to Cablevision Systems Corporation's support, which made a multi-year commitment to underwrite all of Lustgarten's administrative costs so that 100 percent of every donation goes directly to scientific research.

"Many of these grant recipients will build on the landmark work of The Genome Project, which decoded pancreatic cancer's complete genetic blueprint, while others are conducting research essential to our growing understanding of pancreatic cancer. If successful, this research will move us another step closer toward the goal of making pancreatic cancer detection as easy as a routine blood test, and provide the framework for developing life-saving treatments," said Kerri Kaplan, executive director of The Lustgarten Foundation.

Of note, the new three-year grant for $825,000 awarded to Dr. Bert Vogelstein of Johns Hopkins University allows scientists to identify potential DNA biomarkers present in pancreatic cancer patients. If successful, it would represent a major step forward in combating a disease where early treatment is the best hope for survival.

The first 2009 Lustgarten Foundation grants went to Nita Ahuja, Johns Hopkins University; Allan Balmain, University of California, San Francisco; Sunil R. Hingorani, Fred Hutchinson Cancer Research Center; Alison Klein, Johns Hopkins University; Chandan Kumar, University of Michigan Medical School; Joshua Mendell, Johns Hopkins University School of Medicine; Thomas D. Schmittgen, Ohio State University; Jeffrey Settleman, Massachusetts General Hospital; and Bert Vogelstein, Johns Hopkins University School of Medicine.

About The Lustgarten Foundation

Pancreatic cancer is the fourth-leading cause of cancer deaths in the United States. More than 34,000 people die from it each year. Of those diagnosed with pancreatic cancer, five percent survive five years and most with advanced cancer die within a year.

The Lustgarten Foundation is America's largest private foundation working solely on pancreatic cancer research. The Foundation has provided $22 million to more than 110 research projects. To learn more, visit www.lustgarten.org.


'/>"/>
SOURCE The Lustgarten Foundation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. The Lustgarten Foundation for Pancreatic Cancer Research Launches New Public Service Announcement Featuring Last Lecturer Dr. Randy Pausch
2. Lustgarten Foundation Announces $1.25 Million Commitment to Pancreatic Cancer Biomarker Development Project
3. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
4. Americas on the Waterway Supports US Oncology Foundation
5. Prometheus Research Signs 3-Year Contract With Simons Foundation to Expand HTSQL Informatics System for Autism Research
6. The Foundation for Biomedical Research Wins Telly Award for Majestic
7. Leaders in Health Literacy Recognized by the Partnership for Clear Health Communication at the National Patient Safety Foundation
8. Healthcare Leaders to Address Patient Safety and Reform at the National Patient Safety Foundation Congress, Washington, DC, May 20-22
9. PTC Therapeutics and Spinal Muscular Atrophy Foundation Announce $8.5 Million Small Molecule Development Collaboration
10. Pearson Foundation Supports Incoming LSU Biology Students With 21st Century Learning Tools
11. The Crohns & Colitis Foundation of America and Shire Launch Virtual IBD March on the Hill to Increase Funding for Digestive Disease Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... MILFORD, Mass. , March 23, 2017 ... leading partner to global in vitro diagnostics ... launch of the industry,s first multiplexed ... inherited disease testing by next-generation sequencing ... materials were developed with input from industry ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
(Date:3/22/2017)... 22, 2017  Ascendis Pharma A/S (Nasdaq: ASND), ... technology to address significant unmet medical needs in ... full year ended December 31, 2016. ... company as we broadened our pipeline and pursued ... disease company with an initial focus on endocrinology," ...
Breaking Biology Technology:
(Date:3/2/2017)... -- Summary This report provides all the ... its partnering interests and activities since 2010. Download ... Partnering Deals and Alliance since 2010 report provides an ... the world,s leading life sciences companies. On ... inclusion of the most up to date deal and ...
(Date:2/28/2017)... , February 28, 2017 News solutions for ... ... from 14 to 16 March, Materna will present ... show how seamless travel is a real benefit for passengers. ... biometrics to their passenger touch point solutions to take passengers through ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
Breaking Biology News(10 mins):